Prot# H3E-MC-JMIG(a): Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients with Unresectable, Loc

Project: Research project

Project Details

StatusFinished
Effective start/end date7/16/10 → 12/14/14

Funding

  • Eli Lilly and Company (H3E-MC-JMIG(a))